Ptpn11 Is A Novel Anti-Fibrotic Gene In Idiopathic Pulmonary Fibrosis

被引:0
|
作者
Tzouvelekis, A. [1 ,2 ]
Cardenas, C. Lacks Lino [2 ]
Yu, G. [1 ]
Sakamoto, K. [1 ]
DeIuliis, J. [1 ]
Wyllie, A. [3 ]
Ahangari, F. [1 ]
Woolard, T. [1 ]
Heather, L. [1 ]
Herazo-Maya, J. D. [1 ]
Kaminski, N. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Yale Univ, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2356
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
    Astor, Todd L. L.
    Goldberg, Hilary J. J.
    Snyder, Laurie D. D.
    Courtwright, Andrew
    Hachem, Ramsey
    Pena, Tahuanty
    Zaffiri, Lorenzo
    Criner, Gerard J. J.
    Budev, Marie M. M.
    Thaniyavarn, Tany
    Leonard, Thomas B. B.
    Bender, Shaun
    Barakat, Aliaa
    Breeze, Janis L. L.
    LaCamera, Peter
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [12] Real-World Tolerability Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Shlobin, O.
    Ahmad, S.
    Weir, N.
    Nathan, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [13] Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
    Khor, Yet H.
    Ng, Yvonne
    Barnes, Hayley
    Goh, Nicole S. L.
    McDonald, Christine F.
    Holland, Anne E.
    EUROPEAN RESPIRATORY REVIEW, 2020, 29 (157): : 1 - 16
  • [14] Clinical Characteristics of Progressive Pulmonary Fibrosis of Idiopathic Pulmonary Fibrosis Patients Who Receive Anti-fibrotic Agent
    Kishaba, T.
    Nagano, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [15] Anti-Fibrotic Effects Of Inhaled Interferon-Gamma Detected By Gene Expression In Patients With Idiopathic Pulmonary Fibrosis
    Condos, R.
    Hasaneen, N. A.
    Foda, H. D.
    Smaldone, G. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [16] Concomitant corticosteroid with anti-fibrotic therapy for idiopathic pulmonary fibrosis: a prospective multicenter study
    Kato, Motoyasu
    Miyamoto, Atsushi
    Izumi, Shinyu
    Inomata, Minoru
    Kamio, Koichiro
    Sumikawa, Hiromitsu
    Egashira, Ryoko
    Sugiura, Hiroaki
    Araya, Jun
    Takeuchi, Masahiro
    Takahashi, Kazuhisa
    Azuma, Arata
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [17] Evaluation of Extracellular Matrix Biomarkers in Response to Anti-Fibrotic Treatment of Idiopathic Pulmonary Fibrosis
    Jessen, H.
    Hoyer, N.
    Ronnow, S.
    Karsdal, M.
    Leeming, D. J.
    Sand, J. M.
    Shaker, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [18] Nonsyndromic pulmonary valve stenosis and the PTPN11 gene
    Sarkozy, A
    Conti, E
    Esposito, G
    Pizzuti, A
    Dallapiccola, B
    Mingarelli, R
    Marino, B
    Digilio, MC
    Paoletti, V
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 116A (04): : 389 - 390
  • [19] A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
    Roach, Katy M.
    Sutcliffe, Amanda
    Matthews, Laura
    Elliott, Gill
    Newby, Chris
    Amrani, Yassine
    Bradding, Peter
    SCIENTIFIC REPORTS, 2018, 8
  • [20] A review of Idiopathic Pulmonary Fibrosis patients on anti-fibrotic treatment in the mid west area
    Ryan, N.
    Ryan, P.
    Gleeson, E.
    Cullinan, M.
    Mcinerney, C.
    Casserly, B.
    O'Brien, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S441 - S442